Abstract
Started with the recent turmoil in the White House, the author further collected some examples of failure of disclosure of financial conflicts of interests between drug companies and researchers that lead to scandals and their aftermath. The author concluded that both politicians and researchers should hold high morality as to gain trust to people. The solution is to actively and voluntarily disclose any potential conflicts of interest in advance rather than impose strict regulations, as the latter may have some opposite effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
